Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through ...

Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...

A research group led by Professor Michael Glickman, dean of Technion's Faculty of Biology, has uncovered a key mechanism in ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...

A research team has developed a next-generation anti-inflammatory protein using AI and supercomputing. The team, led by ...

Israeli and Dutch researchers have unveiled a new technique that allows scientists to precisely measure toxic protein clumps associated with Alzheimer's disease -- something that has long been out of ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most known CRISPR systems target invading pathogens' DNA and chop it up to ...

Your next favorite true crime podcast might have some new forensics jargon to make sense of. Researchers in Australia have developed a new way to identify humans – similar to how we do with DNA and ...

Producing functional membrane proteins remains a major hurdle in both drug discovery and structural biology. While these proteins are central to cellular signaling and serve as key therapeutic targets ...

Dr Dana Rizk is Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB) and a VOYXACT VISIONARY Study Investigator and Co-Chair of the Steering Committee.

Protein aggregation exhibits a dual role in biology, especially in neural systems. While pathogenic aggregates of proteins such as Aβ, tau, and α-synuclein ...